Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, +122

The Lancet

Percutaneous Coronary InterventionControlled Syntax TrialEndovascular TechniqueCardiovascular DiseaseHealth Policy +6

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

Michael H. Davidson, Thomas McGarry, Robert Bettis, +6

Journal of the American College of Cardiology

ThrombosisPrimary HypercholesterolemiaLipid DisorderCardiovascular DiseasePharmacology +5

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

Gregg W. Stone, Stephen G. Ellis, Charles D O'Shaughnessy, +8

PubMed

Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions

Mark Turco, John A. Ormiston, Jeffrey J. Popma, +12

Journal of the American College of Cardiology

De Novo LesionsVascular SurgeryLumen-apposing Metal StentSurgeryNeovascularization +1

The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty

Thomas McGarry, Ronald S. Gottlieb, Joel Morganroth, +5

American Heart Journal

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseaseVascular Surgery +8

Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent

Mark Turco, John A. Ormiston, Jeffrey J. Popma, +10

JACC: Cardiovascular Interventions

ThrombosisPercutaneous Coronary InterventionLong LesionsCardiovascular DiseaseCardiology +8

Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)

Eugenia Nikolsky, Edward Kosinski, Gregory Mishkel, +7

The American Journal of Cardiology

ObesityDrug-eluting Stent ImplantationEndovascular TechniqueCardiovascular DiseaseAtherosclerosis +7

Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial

David J. Cohen, Tara A. Lavelle, Ben van Hout, +12

Catheterization and Cardiovascular Interventions

A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial

Louis Cannon, Dean J. Kereiakes, Tift Mann, +12

EuroIntervention

TAXUS Liberté Attenuates the Risk of Restenosis in Patients With Medically Treated Diabetes Mellitus

Ehtisham Mahmud, John A. Ormiston, Mark Turco, +10

JACC: Cardiovascular Interventions

Metabolic SyndromeDiabetes ManagementDiabetesTaxus LibertéDiabetes Mellitus +1